Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition.
In the context of the reality that pharmaceutical manufacturers and retailers are simultaneously opening online sales channels, three different multi-channel pharmaceutical supply chain game models were constructed based on game theory, considering channel power, triple price competition among chann...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849720071837974528 |
|---|---|
| author | Yan Wen Yan Wei Xiyuan Yu |
| author_facet | Yan Wen Yan Wei Xiyuan Yu |
| author_sort | Yan Wen |
| collection | DOAJ |
| description | In the context of the reality that pharmaceutical manufacturers and retailers are simultaneously opening online sales channels, three different multi-channel pharmaceutical supply chain game models were constructed based on game theory, considering channel power, triple price competition among channels, and health insurance reimbursement policies, among others, comparing and analyzing the effects of each influencing factor on pharmaceutical pricing and profits in the pharmaceutical supply chain. It was found that inter-channel price competition did not always reduce the prices of a retailer's pharmaceuticals; price competition between physical retail channels and online retail channels could lead to higher pharmaceutical prices, but direct sales channels effectively reduced pharmaceutical prices. Furthermore, as the channel power of pharmaceutical retailers strengthens, retail prices will increase, and retailers' profits will rise. However, as the channel power of pharmaceutical manufacturers increases, their profits will grow, but retail prices will correspondingly decrease. Appropriate increasing in the health insurance reimbursement rate could improve pharmaceutical pricing in each channel and the total profits of the pharmaceutical supply chains. |
| format | Article |
| id | doaj-art-60e9cc09f21d43e3bb5dd86b884e5b5c |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-60e9cc09f21d43e3bb5dd86b884e5b5c2025-08-20T03:12:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01205e032214310.1371/journal.pone.0322143Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition.Yan WenYan WeiXiyuan YuIn the context of the reality that pharmaceutical manufacturers and retailers are simultaneously opening online sales channels, three different multi-channel pharmaceutical supply chain game models were constructed based on game theory, considering channel power, triple price competition among channels, and health insurance reimbursement policies, among others, comparing and analyzing the effects of each influencing factor on pharmaceutical pricing and profits in the pharmaceutical supply chain. It was found that inter-channel price competition did not always reduce the prices of a retailer's pharmaceuticals; price competition between physical retail channels and online retail channels could lead to higher pharmaceutical prices, but direct sales channels effectively reduced pharmaceutical prices. Furthermore, as the channel power of pharmaceutical retailers strengthens, retail prices will increase, and retailers' profits will rise. However, as the channel power of pharmaceutical manufacturers increases, their profits will grow, but retail prices will correspondingly decrease. Appropriate increasing in the health insurance reimbursement rate could improve pharmaceutical pricing in each channel and the total profits of the pharmaceutical supply chains.https://doi.org/10.1371/journal.pone.0322143 |
| spellingShingle | Yan Wen Yan Wei Xiyuan Yu Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. PLoS ONE |
| title | Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. |
| title_full | Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. |
| title_fullStr | Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. |
| title_full_unstemmed | Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. |
| title_short | Multi-channel pricing strategies for pharmaceutical supply chains considering channel power and price competition. |
| title_sort | multi channel pricing strategies for pharmaceutical supply chains considering channel power and price competition |
| url | https://doi.org/10.1371/journal.pone.0322143 |
| work_keys_str_mv | AT yanwen multichannelpricingstrategiesforpharmaceuticalsupplychainsconsideringchannelpowerandpricecompetition AT yanwei multichannelpricingstrategiesforpharmaceuticalsupplychainsconsideringchannelpowerandpricecompetition AT xiyuanyu multichannelpricingstrategiesforpharmaceuticalsupplychainsconsideringchannelpowerandpricecompetition |